PTK2-mediated degradation of ATG3 impedes cancer cells susceptible to DNA damage treatment

Abstract

ATG3 (autophagy-related 3) is an E2-like enzyme essential for autophagy; however, it is unknown whether it has an autophagy-independent function. Here, we report that ATG3 is a relatively stable protein in unstressed cells, but it is degraded in response to DNA-damaging agents such as etoposide or cisplatin. With mass spectrometry and a mutagenesis assay, phosphorylation of tyrosine 203 of ATG3 was identified to be a critical modification for its degradation, which was further confirmed by manipulating ATG3 (phosphorylation mimic) or ATG3 (phosphorylation-incompetent) in Atg3 knockout MEFs. In addition, by using a generated phospho-specific antibody we showed that phosphorylation of Y203 significantly increased upon etoposide treatment. With a specific inhibitor or siRNA, PTK2 (protein tyrosine kinase 2) was confirmed to catalyze the phosphorylation of ATG3 at Y203. Furthermore, a newly identified function of ATG3 was recognized to be associated with the promotion of DNA damage-induced mitotic catastrophe, in which ATG3 interferes with the function of BAG3, a crucial protein in the mitotic process, by binding. Finally, PTK2 inhibition-induced sustained levels of ATG3 were able to sensitize cancer cells to DNA-damaging agents. Our findings strengthen the notion that targeting PTK2 in combination with DNA-damaging agents is a novel strategy for cancer therapy.

The role of miR-106p-5p in cervical cancer: from expression to molecular mechanism

“…In terms of PTK2, it is a cytoplasmic protein tyrosine kinase and has an expression in various solid tumors such as ovarian cancer, gastric cancer, and bladder cancer 29 . It is found that PTK2 is associated with the sensitivity of colon cancer cells to DNA damage therapy 30 . However, there are few reports of PTK2 in CC.…”

MicroRNA‐1 overexpression increases chemosensitivity of non‐small cell lung cancer cells by inhibiting autophagy related 3‐mediated autophagy

“…For instance, DDP could induce autophagy and facilitate expression of autophagy‐related genes (ATG3, ATG5, and ATG12) in ovarian cancer cells (Bao et al, ). Additionally, among tested ATG proteins (ATG3, ATG7, ATG10, and ATG12‐ATG5), only ATG3 protein expression was downregulated following the treatment of DDP in human colon cancer cells (Ma et al, ). LC3B‐II and ATG3 expressions were increased and p62 expression was reduced in erlotinib resistant PC9 cells (ERPC9) than that in PC9 cells, and the silencing of ATG3 and the addition of 3MA could weaken resistance of ERPC9 cells to erlotinib and DDP (Lee and Wu, ).…”

Huaier suppresses proliferative and metastatic potential of prostate cancer PC3 cells via downregulation of Lamin�B1 and induction of autophagy

“…5B). A series of autophagy-related proteins partic-ipate in different stages of autophagosome formation, such as Atg3, Atg5 and Beclin-1 (30)(31)(32)(33). LC3 is an autophagosomal marker protein (34).…”